Prophylaxis and Treatment of Menstrual Migraine

被引：0
作者：
D'Arcy, Yvonne M. [1 ]
机构：
[1] Suburban Hosp Johns Hopkins Med, Bethesda, MD USA
来源：
PAIN MANAGEMENT NURSING | 2011年 / 12卷 / 01期
关键词：
UNITED-STATES; HEADACHE; PREVALENCE; PREVENTION; EPIDEMIOLOGY; FROVATRIPTAN; COMORBIDITY; ALLODYNIA; ESTROGEN; BURDEN;
D O I：
10.1016/j.pmn.2010.11.002
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
Migraine is a very disabling condition that can severely impair quality of life. Eighteen percent of women suffer from migraine headaches, and of those, approximately 60% have migraines near the time of their menstrual period. Migraine is generally undertreated, not only because some sufferers do not have access to proper care, but also because many fail to seek treatment because of misperceptions that nothing can be done for a condition from which generations of women have suffered. Research has shown that migraine is not a disorder of blood vessels, but rather a brain disorder characterized by inflammation. The goal of this paper is to explain practical approaches to managing menstrual migraine. (C) 2011 by the American Society for Pain Management Nursing
引用
收藏
页码：S11 / S16
页数：6
相关论文
共 35 条
[1]   Comorbidity of headache and gastrointestinal complaints. The Head-HUNT study [J].
Aamodt, A. H. ;
Stovner, L. J. ;
Hagen, K. ;
Zwart, J-A .
CEPHALALGIA, 2008, 28 (02) :144-151
[2]   Prevalence and characteristics of allodynia in headache sufferers - A population study [J].
Bigal, M. E. ;
Ashina, S. ;
Burstein, R. ;
Reed, M. L. ;
Buse, D. ;
Serrano, D. ;
Lipton, R. B. .
NEUROLOGY, 2008, 70 (17) :1525-1533
[3]   Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks [J].
Brandes, J. L. ;
Poole, A. C. ;
Kallela, M. ;
Schreiber, C. P. ;
MacGregor, E. A. ;
Silberstein, S. D. ;
Tobin, J. ;
Shaw, R. .
CEPHALALGIA, 2009, 29 (11) :1133-1148
[4]   Migraine and Functional Impairment [J].
Brandes, Jan Lewis .
CNS DRUGS, 2009, 23 (12) :1039-1045
[5]   The influence of estrogen on migraine - A systematic review [J].
Brandes, JL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (15) :1824-1830
[6]   Hormonal therapies for menstrual migraine [J].
Calhoun, Anne H. ;
Hutchinson, Susan .
CURRENT PAIN AND HEADACHE REPORTS, 2009, 13 (05) :381-385
[7]   Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain [J].
Chou, Roger ;
Fanciullo, Gilbert J. ;
Fine, Perry G. ;
Adler, Jeremy A. ;
Ballantyne, Jane C. ;
Davies, Pamela ;
Donovan, Marilee I. ;
Fishbain, David A. ;
Foley, Kathy M. ;
Fudin, Jeffrey ;
Gilson, Aaron M. ;
Kelter, Alexander ;
Mauskop, Alexander ;
O'Connor, Patrick G. ;
Passik, Steven D. ;
Pasternak, Gavril W. ;
Portenoy, Russell K. ;
Rich, Ben A. ;
Roberts, Richard G. ;
Todd, Knox H. ;
Miaskowski, Christine .
JOURNAL OF PAIN, 2009, 10 (02) :113-130
[8]   Patterns of diagnosis and acute and preventive treatment for migraine in the United States: Results from the American Migraine Prevalence and Prevention study [J].
Diamond, Seymour ;
Bigal, Marcelo E. ;
Silberstein, Stephen ;
Loder, Elizabeth ;
Reed, Michael ;
Lipton, Richard B. .
HEADACHE, 2007, 47 (03) :355-363
[9]   New drugs in migraine treatment and prophylaxis: telcagepant and topiramate [J].
Edvinsson, Lars ;
Linde, Mattias .
LANCET, 2010, 376 (9741) :645-655
[10]   EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force [J].
Evers, S. ;
Afra, J. ;
Frese, A. ;
Goadsby, P. J. ;
Linde, M. ;
May, A. ;
Sandor, P. S. .
EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (09) :968-981
1234